ESC guidance on heart disease and COVID-19


  • Dawn O'Shea
  • Univadis Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The European Society of Cardiology has published guidance on the diagnosis and management of cardiovascular diseases during the COVID-19 epidemic.

The SARS-CoV-2 virus not only causes viral pneumonia but also has major implications for the cardiovascular system. Heart and stroke patients are more likely to have severe cases of COVID-19, as are people with other risk factors, including advanced age, diabetes, hypertension and obesity. In addition, COVID-19 therapies themselves may lead to heart damage.

Issues addressed in the guidance include the following:

  • Cardiovascular manifestations on COVID-19
  • Impact of cardiovascular comorbidities on COVID-19 infection outcomes
  • Diagnosis and treatment of cardiovascular conditions in COVID-19 patients
  • Acute cardiac injury and myocarditis in patients with COVID-19
  • The relationship between hypertension, ACE-2, and COVID-19
  • Strategies for diagnosing COVID-19
  • The use of anticoagulants in patients with COVID-19
  • Categorisation of urgency for invasive procedures

The full guidelines can be found here.